These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11709313)

  • 41. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
    Larsen MH; Vilchèze C; Kremer L; Besra GS; Parsons L; Salfinger M; Heifets L; Hazbon MH; Alland D; Sacchettini JC; Jacobs WR
    Mol Microbiol; 2002 Oct; 46(2):453-66. PubMed ID: 12406221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of fluoroquinolone activity by C-8 halogen and methoxy moieties: action against a gyrase resistance mutant of Mycobacterium smegmatis and a gyrase-topoisomerase IV double mutant of Staphylococcus aureus.
    Lu T; Zhao X; Li X; Drlica-Wagner A; Wang JY; Domagala J; Drlica K
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2703-9. PubMed ID: 11557458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of Mycobacterium smegmatis deficient in ADP-ribosyltransferase as surrogate for Mycobacterium tuberculosis in drug testing and mutation analysis.
    Agrawal P; Miryala S; Varshney U
    PLoS One; 2015; 10(4):e0122076. PubMed ID: 25874691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A rifampin-hypersensitive mutant reveals differences between strains of Mycobacterium smegmatis and presence of a novel transposon, IS1623.
    Alexander DC; Jones JR; Liu J
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3208-13. PubMed ID: 14506032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors.
    Altaf M; Miller CH; Bellows DS; O'Toole R
    Tuberculosis (Edinb); 2010 Nov; 90(6):333-7. PubMed ID: 20933470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations.
    Zhou J; Dong Y; Zhao X; Lee S; Amin A; Ramaswamy S; Domagala J; Musser JM; Drlica K
    J Infect Dis; 2000 Aug; 182(2):517-25. PubMed ID: 10915083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a Mycobacterium tuberculosis gene that enhances mycobacterial survival in macrophages.
    Wei J; Dahl JL; Moulder JW; Roberts EA; O'Gaora P; Young DB; Friedman RL
    J Bacteriol; 2000 Jan; 182(2):377-84. PubMed ID: 10629183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA.
    Hegde SS; Vetting MW; Roderick SL; Mitchenall LA; Maxwell A; Takiff HE; Blanchard JS
    Science; 2005 Jun; 308(5727):1480-3. PubMed ID: 15933203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of a natural transport system in the process of efflux-mediated drug resistance in Mycobacterium smegmatis.
    Banerjee SK; Bhatt K; Misra P; Chakraborti PK
    Mol Gen Genet; 2000 Jan; 262(6):949-56. PubMed ID: 10660056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-Guérin, and Mycobacterium tuberculosis H37Rv by allelic exchange.
    Pavelka MS; Jacobs WR
    J Bacteriol; 1999 Aug; 181(16):4780-9. PubMed ID: 10438745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci.
    Jorgensen JH; Weigel LM; Ferraro MJ; Swenson JM; Tenover FC
    Antimicrob Agents Chemother; 1999 Feb; 43(2):329-34. PubMed ID: 9925527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noncanonical SMC protein in Mycobacterium smegmatis restricts maintenance of Mycobacterium fortuitum plasmids.
    Panas MW; Jain P; Yang H; Mitra S; Biswas D; Wattam AR; Letvin NL; Jacobs WR
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13264-71. PubMed ID: 25197070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Small-colony mutants of Staphylococcus aureus allow selection of gyrase-mediated resistance to dual-target fluoroquinolones.
    Pan XS; Hamlyn PJ; Talens-Visconti R; Alovero FL; Manzo RH; Fisher LM
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2498-506. PubMed ID: 12121924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis.
    Pasca MR; Guglierame P; De Rossi E; Zara F; Riccardi G
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4775-7. PubMed ID: 16251328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.
    Mustaev A; Malik M; Zhao X; Kurepina N; Luan G; Oppegard LM; Hiasa H; Marks KR; Kerns RJ; Berger JM; Drlica K
    J Biol Chem; 2014 May; 289(18):12300-12. PubMed ID: 24497635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae.
    Nagai K; Davies TA; Pankuch GA; Dewasse BE; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2740-6. PubMed ID: 10991854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Mycobacterial Efflux Pump EfpA Can Induce High Drug Tolerance to Many Antituberculosis Drugs, Including Moxifloxacin, in Mycobacterium smegmatis.
    Rai D; Mehra S
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0026221. PubMed ID: 34424047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis.
    Rodrigues L; Wagner D; Viveiros M; Sampaio D; Couto I; Vavra M; Kern WV; Amaral L
    J Antimicrob Chemother; 2008 May; 61(5):1076-82. PubMed ID: 18310137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The alternative sigma factor SigF of Mycobacterium smegmatis is required for survival of heat shock, acidic pH and oxidative stress.
    Gebhard S; Hümpel A; McLellan AD; Cook GM
    Microbiology (Reading); 2008 Sep; 154(Pt 9):2786-2795. PubMed ID: 18757812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovafloxacin.
    Bébéar CM; Grau O; Charron A; Renaudin H; Gruson D; Bébéar C
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2719-27. PubMed ID: 10991851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.